Literature DB >> 25339505

IGF-1 signaling via the PI3K/Akt pathway confers neuroprotection in human retinal pigment epithelial cells exposed to sodium nitroprusside insult.

Haitao Wang1, Sufen Liao, Ruojun Geng, Yongxin Zheng, Rifang Liao, Fengxia Yan, Thilini Thrimawithana, Peter J Little, Zhong-Ping Feng, Philip Lazarovici, Wenhua Zheng.   

Abstract

The pathological increase in the levels of the second messenger nitric oxide (NO) in the vitreous cavity and retina leads to injury and cell death of the retinal pigment epithelium (RPE) cells and eventually may contribute to the occurrence and development of diabetic retinopathy. In this study, we developed a cellular model of retinopathy using D407 cells (a human RPE cell line) exposed to sodium nitroprusside (SNP) and investigated the protective effect of the insulin-like growth factor-1 (IGF-1) towards this insult. Cell death and apoptosis were examined by the methyl thiazolyl tetrazolium assay and Hoechst staining, respectively. Specific inhibitors were used and phosphorylation of relevant signaling proteins was determined by Western blotting. SNP, in a concentration-dependent fashion, increased the production of reactive oxygen species (ROS) and lipid peroxidation process causing cell death by apoptosis of D407 cells. IGF-1, in a time- and dose-dependent manner, conferred protection towards SNP-mediated insult. Both phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt) and mitogen-activated protein kinase (MAPK) were activated by IGF-1 in relation to the protective effect. Blockade of the PI3K/Akt pathway abolished the protective effect of IGF-1 whereas inhibition of the MAPK pathway was ineffective. SNP decreased the phosphorylation of Akt in the cells while IGF-1 reversed this inhibitory effect. These results indicate that the protective effect of IGF-1 on D407 exposed to SNP insult is mediated by the PI3K/Akt pathway. This proposal may be exploited in the clinic to improve the viability of insulted retinal cells for maintaining physiological vision.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25339505     DOI: 10.1007/s12031-014-0448-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  38 in total

1.  Systemic IGF-I treatment inhibits cell death in diabetic rat retina.

Authors:  Gail M Seigel; Sean B Lupien; Lorrie M Campbell; Douglas N Ishii
Journal:  J Diabetes Complications       Date:  2006 May-Jun       Impact factor: 2.852

2.  Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy.

Authors:  R E Schmidt; D A Dorsey; L N Beaudet; S B Plurad; C A Parvin; M S Miller
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy.

Authors:  Anusha Mishra; Eric A Newman
Journal:  Glia       Date:  2010-12       Impact factor: 7.452

4.  Evidence for an insulin-like growth factor autocrine-paracrine system in the retinal photoreceptor-pigment epithelial cell complex.

Authors:  R J Waldbillig; B A Pfeffer; T J Schoen; A A Adler; Z Shen-Orr; L Scavo; D LeRoith; G J Chader
Journal:  J Neurochem       Date:  1991-11       Impact factor: 5.372

5.  Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.

Authors:  P M Jehle; D R Jehle; S Mohan; B O Böhm
Journal:  J Endocrinol       Date:  1998-11       Impact factor: 4.286

6.  Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells.

Authors:  D M Martin; D Yee; E L Feldman
Journal:  Brain Res Mol Brain Res       Date:  1992-01

7.  Systemic Insulin-like growth factor-1 reverses hypoalgesia and improves mobility in a mouse model of diabetic peripheral neuropathy.

Authors:  Qiuming Chu; Rod Moreland; Nelson S Yew; Joseph Foley; Robin Ziegler; Ronald K Scheule
Journal:  Mol Ther       Date:  2008-06-10       Impact factor: 11.454

8.  S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.

Authors:  Mariana A B Rosales; Kamila C Silva; Diego A Duarte; Marcelo G de Oliveira; Gabriela F P de Souza; Rodrigo R Catharino; Mônica S Ferreira; Jose B Lopes de Faria; Jacqueline M Lopes de Faria
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-02       Impact factor: 4.799

9.  HIV-1 Tat protein alter the tight junction integrity and function of retinal pigment epithelium: an in vitro study.

Authors:  Ling Bai; Zhenping Zhang; Hui Zhang; Xiumei Li; Qiurong Yu; Haotian Lin; Wenhui Yang
Journal:  BMC Infect Dis       Date:  2008-06-06       Impact factor: 3.090

Review 10.  An overview of the eye in diabetes.

Authors:  Anil Negi; Stephen A Vernon
Journal:  J R Soc Med       Date:  2003-06       Impact factor: 18.000

View more
  20 in total

1.  Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis.

Authors:  Seok-Jo Kim; Paul Cheresh; Mesut Eren; Renea P Jablonski; Anjana Yeldandi; Karen M Ridge; G R Scott Budinger; Dong-Hyun Kim; Myles Wolf; Douglas E Vaughan; David W Kamp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-04-20       Impact factor: 5.464

2.  Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.

Authors:  Bingqing Zeng; Yiwen Li; Bo Niu; Xinyi Wang; Yufang Cheng; Zhongzhen Zhou; Tingting You; Yonggang Liu; Haitao Wang; Jiangping Xu
Journal:  J Mol Neurosci       Date:  2016-07-13       Impact factor: 3.444

3.  Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.

Authors:  S D'Antoni; E Ranno; M Spatuzza; S Cavallaro; M V Catania
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

4.  Protective Effect of L-Theanine on Cadmium-Induced Apoptosis in PC12 Cells by Inhibiting the Mitochondria-Mediated Pathway.

Authors:  Peiling Ben; Zhengping Zhang; Chunxia Xuan; Shasha Sun; Lei Shen; Yanhong Gao; Xiang Cao; Yi Zhou; Lei Lan; Zhimin Yin; Lan Luo
Journal:  Neurochem Res       Date:  2015-07-12       Impact factor: 3.996

5.  Glutamate Inhibits the Pro-Survival Effects of Insulin-Like Growth Factor-1 on Retinal Ganglion Cells in Hypoxic Neonatal Rat Retina.

Authors:  Gurugirijha Rathnasamy; Wallace S Foulds; Eng Ang Ling; Charanjit Kaur
Journal:  Mol Neurobiol       Date:  2016-05-14       Impact factor: 5.590

6.  Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury.

Authors:  Rifang Liao; Fengxia Yan; Zhuanping Zeng; Haitao Wang; Kaifeng Qiu; Jinying Xu; Wenhua Zheng
Journal:  Br J Pharmacol       Date:  2017-12-08       Impact factor: 8.739

7.  Nerve growth factor protects against palmitic acid-induced injury in retinal ganglion cells.

Authors:  Pan-Shi Yan; Shu Tang; Hai-Feng Zhang; Yuan-Yuan Guo; Zhi-Wen Zeng; Qiang Wen
Journal:  Neural Regen Res       Date:  2016-11       Impact factor: 5.135

8.  Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy.

Authors:  Menaka C Thounaojam; Folami L Powell; Sagar Patel; Diana R Gutsaeva; Amany Tawfik; Sylvia B Smith; Julian Nussbaum; Norman L Block; Pamela M Martin; Andrew V Schally; Manuela Bartoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-27       Impact factor: 12.779

9.  H2O2 attenuates IGF-1R tyrosine phosphorylation and its survival signaling properties in neuronal cells via NR2B containing NMDA receptor.

Authors:  Zhiwen Zeng; Dejun Wang; Uma Gaur; Liao Rifang; Haitao Wang; Wenhua Zheng
Journal:  Oncotarget       Date:  2017-06-27

10.  Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma.

Authors:  Stephanie A Leopold; Ludwig F Zeilbeck; Gregor Weber; Roswitha Seitz; Michael R Bösl; Herbert Jägle; Rudolf Fuchshofer; Ernst R Tamm; Andreas Ohlmann
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.